Kintara Therapeutics Quote - KTRA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

7.539

Bid

0.2199

Ask

0.22

Volume

0.00 Day's Range 0.00

2.835 52 Week Range 14.595

Market Cap

419.625M

Previous Close

7.539

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

55,660,578

Dividend Yield

PE Ratio

-49.38

Earnings Per Share (EPS)

-0.15

Revenue

Net Profit

-8.5M

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kintara.com

Headquarters

Reno, Nevada, USA

Founded

Kintara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KTRA. The last closing price for Kintara Therapeutics was US$7.54. Over the last year, Kintara Therapeutics shares have traded in a share price range of US$ 2.835 to US$ 14.595.

Kintara Therapeutics currently has 55,660,578 shares outstanding. The market capitalization of Kintara Therapeutics is US$419.63 million. Kintara Therapeutics has a price to earnings ratio (PE ratio) of -49.38.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	7.539	7.539	7.539	0	0	CS
4	0	0	7.539	7.539	7.539	0	0	CS
12	0	0	7.539	7.539	7.539	0	0	CS
26	-2.261	-23.0714285714	9.8	10.493	5.4355	1508700	7.11430717	CS
52	2.6425	53.967119371	4.8965	14.595	2.835	7464074	6.21558449	CS
156	-797.461	-99.0634782609	805	1470	2.835	3610881	84.4863086	CS
260	-2109.961	-99.6439669421	2117.5	5862.5	2.835	2772167	368.07818439	CS

KTRA - Frequently Asked Questions (FAQ)

What is the current Kintara Therapeutics share price?

The current share price of Kintara Therapeutics is US$ 7.539

How many Kintara Therapeutics shares are in issue?

Kintara Therapeutics has 55,660,578 shares in issue

What is the market cap of Kintara Therapeutics?

The market capitalisation of Kintara Therapeutics is USD 419.63M

What is the 1 year trading range for Kintara Therapeutics share price?

Kintara Therapeutics has traded in the range of US$ 2.835 to US$ 14.595 during the past year

What is the PE ratio of Kintara Therapeutics?

The price to earnings ratio of Kintara Therapeutics is -49.38

What is the reporting currency for Kintara Therapeutics?

Kintara Therapeutics reports financial results in USD

What is the latest annual profit for Kintara Therapeutics?

The latest annual profit of Kintara Therapeutics is USD -8.5M

What is the registered address of Kintara Therapeutics?

The registered address for Kintara Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501

What is the Kintara Therapeutics website address?

The website address for Kintara Therapeutics is www.kintara.com

Which industry sector does Kintara Therapeutics operate in?

Kintara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SGBXSafe and Green Holdings Corporation	US$ 1.24 (129.63%)	32.22M
SGDSafe and Green Development Corporation	US$ 3.90 (59.84%)	5.27M
HSDTHelius Medical Technologies Inc	US$ 0.975 (40.90%)	10.71M
DXRDaxor Corporation	US$ 11.83 (40.33%)	11
EOLSEvolus Inc	US$ 13.00 (37.28%)	2
DYNXDynamix Corporation	US$ 5.01 (-48.88%)	1
NESRNational Energy Services Reunited Corporation	US$ 5.11 (-41.47%)	4
KODKodiak Sciences Inc	US$ 5.00 (-34.21%)	111
EBMTEagle Bancorp Montana Inc	US$ 10.01 (-31.90%)	6
HTLMHomesToLife Ltd	US$ 5.20 (-31.13%)	201
SGBXSafe and Green Holdings Corporation	US$ 1.24 (129.63%)	32.22M
GCTKGlucoTrack Inc	US$ 0.0921 (-24.51%)	11.39M
HSDTHelius Medical Technologies Inc	US$ 0.975 (40.90%)	10.71M
WINTWindtree Therapeutics Inc	US$ 0.2353 (-5.84%)	9.82M
RIMEAlgorhythm Holdings Inc	US$ 0.0547 (-30.05%)	8.21M